1. This document provides a material safety data sheet (MSDS) for 1,3,5-trimethoxybenzene, which is offered for sale by suppliers with a CAS number of 621-23-8.
2. The product is off-white crystals that may cause eye, skin, and respiratory irritation upon contact.
3. The MSDS provides information on product identification, composition, health effects, safe handling and storage procedures, firefighting measures, accidental release measures, toxicological properties, ecological information, disposal considerations, transportation information, and regulatory information.
Material Safety Data Sheet (MSDS) for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
cde coconut oil diethanolamine data sheetmadianguc
Color
: dark brown
Physical State
: liquid
Odor
: none
pH : ca.8.0
Odor Threshold
: no data available
Vapor Pressure : no data available
Vapor Density
: Heavier than air
Boiling point/range
: 212
Material Safety Data Sheet (MSDS) for CosmoMix-ACE. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-ACE. The CosmoMix-ACE formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
cde coconut oil diethanolamine data sheetmadianguc
Color
: dark brown
Physical State
: liquid
Odor
: none
pH : ca.8.0
Odor Threshold
: no data available
Vapor Pressure : no data available
Vapor Density
: Heavier than air
Boiling point/range
: 212
Material Safety Data Sheet (MSDS) for CosmoMix-ACE. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-ACE. The CosmoMix-ACE formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE. The Cosmesome-ACE formulation is composed of saturated phospholipids that form interdigitated lipids that contain vitamins A,C, and E in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE. The Dermasome-ACE formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing vitamins A,C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
The document is the Material Safety Data Sheet (MSDS) for Clodronate Encapsulated liposomes (Clodrosome) Manufactured by Encapsula NanoSciences in United States of America
www.clodrosome.com
Material Safety Data Sheet (MSDS) for Dermasome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE (NE). The Dermasome-ACE (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing vitamins A, C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol (NE). The Dermasome-Chol (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for CosmoMix-Chol. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE (NE). The Cosmesome-ACE (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes that contain vitamins A, C and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol. The Dermasome-Chol formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Ubq (NE). The Cosmesome-Ubq (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE. The Cosmesome-ACE formulation is composed of saturated phospholipids that form interdigitated lipids that contain vitamins A,C, and E in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-ACE (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE. The Dermasome-ACE formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing vitamins A,C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
The document is the Material Safety Data Sheet (MSDS) for Clodronate Encapsulated liposomes (Clodrosome) Manufactured by Encapsula NanoSciences in United States of America
www.clodrosome.com
Material Safety Data Sheet (MSDS) for Dermasome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-ACE (NE). The Dermasome-ACE (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing vitamins A, C, and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol (NE). The Dermasome-Chol (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for CosmoMix-Chol. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-ACE (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-ACE (NE). The Cosmesome-ACE (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes that contain vitamins A, C and E upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Chol. The Dermasome-Chol formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Ubq (NE). The Cosmesome-Ubq (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq (NE). The Dermasome-Ubq (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Res (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Res (NE). The Dermasome-Res (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing reveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol (NE). The Cosmesome-Chol (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing cholesterol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Cosmesome-Chol (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Chol. The Cosmesome-Chol formulation is composed of saturated phospholipids that form interdigitated lipids containing cholesterol in the presence of alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing aldehyde PEGylated lipid used for conjugating antibodies, peptides and proteins through an available engineered hydrazide in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing PDP PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
Material Safety Data Sheet (MSDS) for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for Cosmesome-Res (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Res (NE). The Cosmesome-Res (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing resveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Website: https://www.greenlightwindowfilms.com/cities-we-serve/colorado-springs/
Green Light Window Films Colorado Springs.
This file is from Colorado Springs, Colorado. It contains information about window tinting. All information and rights to the material are copyrighted by the company to whom it belongs to. Thank you for viewing. Green Light Window Film hopes you enjoy
Website: https://www.greenlightwindowfilms.com/cities-we-serve/dallas/
Green Light Window Films Dallas.
This file is from Dallas, Texas. It contains information about window tinting. All information and rights to the material are copyrighted by the company to whom it belongs to. Thank you for viewing. Green Light Window Film hopes you enjoy.
Website: https://www.customtintsolutions.com/cities/austin/
Custom Tint Solutions Window Film Austin.
This file is from Austin, Texas. It contains information about window tinting. All information and rights to the material are copyrighted by the company to whom it belongs to. Thank you for viewing. Custom Tint Solutions hopes you enjoy.
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing NHS reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free amine in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing maleimide reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing Biotin PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered avidin in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing DBCO PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered azide through click chemistry in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing folate PEGylated lipid used for targeting folate receptors.
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing amine reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have cabroxylic acid in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing carboxylic acid reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free amine in order to make immunoliposomes.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. Click http://www.guidechem.com/cas-621/621-23-8.html for suppliers of this product
1,3,5-Trimethoxybenzene (cas 621-23-8) MSDS
MSDS : 1,3,5-Trimethoxybenzene, 99%
CAS : 621-23-8
SYNONYMS : phloroglucinol Trimethyl Ether; Sym-Trimethoxybenzene.
Section 1 - Chemical Product and Company Identification
MSDS Name: 1,3,5-Trimethoxybenzene, 99%
Catalog Numbers: AC160550000, AC160550500
Synonyms: Phloroglucinol Trimethyl Ether; Sym-Trimethoxybenzene.
Company Identification:
Acros Organics N.V.
One Reagent Lane
Fair Lawn, NJ 07410
For information in North America, call: 800-ACROS-01
For emergencies in the US, call CHEMTREC: 800-424-9300
Section 2 - Composition, Information on Ingredients
CAS# Chemical Name Percent EINECS/ELINCS
621-23-8 1,3,5-trimethoxybenzene 99% 210-673-4
Section 3 - Hazards Identification
EMERGENCY OVERVIEW
Appearance: off-white crystals. Flash Point: 85 deg C.
Caution! May cause eye and skin irritation. May cause respiratory and digestive tract irritation. The toxicological properties of this material have not been fully
investigated.
Target Organs: No data found.
Potential Health Effects
Eye: May cause eye irritation.
Skin: May cause skin irritation.
Ingestion: May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic: No information found.
Section 4 - First Aid Measures
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4
cupfuls of milk or water.
Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
aid.
Notes to Physician: Treat symptomatically and supportively.
Section 5 - Fire Fighting Measures
General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective
gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Dusts may be combustible when exposed to
heat, flame, or oxidizing agents. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media: In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.
Flash Point: 85 deg C ( 185.00 deg F)
Autoignition Temperature: Not applicable.
Explosion Limits, Lower: Not available.
Upper: Not available.
NFPA Rating: (estimated) Health: 1; Flammability: 1; Instability: 0
Section 6 - Accidental Release Measures
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective
Equipment section. Avoid generating dusty conditions. Provide ventilation.
Section 7 - Handling and Storage
2. Handling: Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and
accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage: Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible
substances.
Section 8 - Exposure Controls, Personal Protection
Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to
keep airborne concentrations low.
Exposure Limits
Chemical Name ACGIH NIOSH OSHA - Final PELs
1,3,5-Trimethoxybenzene none listed none listed none listed
OSHA Vacated PELs: 1,3,5-Trimethoxybenzene: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or
European Standard EN166.
Skin: Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing: Wear appropriate protective clothing to minimize contact with skin.
Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN
149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - Physical and Chemical Properties
Physical State: Crystals
Appearance: off-white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Vapor Density: Not available.
Evaporation Rate: Not available.
Viscosity: Not available.
Boiling Point: 255 deg C @ 760.00mmHg
Freezing/Melting Point: 51.00 - 53.00 deg C
Decomposition Temperature: Not available.
Solubility: insoluble
Specific Gravity/Density: Not available.
Molecular Formula: C9H12O3
Molecular Weight: 168.19
Section 10 - Stability and Reactivity
Chemical Stability: Stable under normal temperatures and pressures.
Conditions to Avoid: Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials: Oxidizing agents.
Hazardous Decomposition Products: Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
Section 11 - Toxicological Information
RTECS#:
CAS# 621-23-8: DC2810000
LD50/LC50:
CAS# 621-23-8:
Oral, mouse: LD50 = 1480 mg/kg;
.
Carcinogenicity:
CAS# 621-23-8: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
Epidemiology: No information found
Teratogenicity: No information found
Reproductive Effects: No information found
Mutagenicity: No information found
Neurotoxicity: No information found
Other Studies:
Section 12 - Ecological Information
No information available.
Section 13 - Disposal Considerations
Chemical waste generators must determine whether a discarded chemical is classified as a hazardous waste. US EPA guidelines for the classification
determination are listed in 40 CFR Parts 261.3. Additionally, waste generators must consult state and local hazardous waste regulations to ensure complete
and accurate classification.
RCRA P-Series: None listed.
RCRA U-Series: None listed.
3. Section 14 - Transport Information
US DOT Canada TDG
Shipping Name: Not regulated as a hazardous material No information available.
Hazard Class:
UN Number:
Packing Group:
Section 15 - Regulatory Information
US FEDERAL
TSCA
CAS# 621-23-8 is listed on the TSCA inventory.
Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA.
CERCLA Hazardous Substances and corresponding RQs
None of the chemicals in this material have an RQ.
SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ.
Section 313 No chemicals are reportable under Section 313.
Clean Air Act:
This material does not contain any hazardous air pollutants.
This material does not contain any Class 1 Ozone depletors.
This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
None of the chemicals in this product are listed as Hazardous Substances under the CWA.
None of the chemicals in this product are listed as Priority Pollutants under the CWA.
None of the chemicals in this product are listed as Toxic Pollutants under the CWA.
OSHA:
None of the chemicals in this product are considered highly hazardous by OSHA.
STATE
CAS# 621-23-8 is not present on state lists from CA, PA, MN, MA, FL, or NJ.
California Prop 65
California No Significant Risk Level: None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek medical advice
immediately (show the label where possible).
S 28A After contact with skin, wash immediately with plenty of water
.
WGK (Water Danger/Protection)
CAS# 621-23-8: No information available.
Canada - DSL/NDSL
CAS# 621-23-8 is listed on Canada's DSL List.
Canada - WHMIS
WHMIS: Not available.
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all of the information
required by those regulations.
Canadian Ingredient Disclosure List
Section 16 - Additional Information
MSDS Creation Date: 9/02/1997
Revision #5 Date: 10/03/2005
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other
warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the
suitability of the information for their particular purposes. In no event shall Fisher be liable for any claims, losses, or damages of any third party or for lost profits or any special,
indirect, incidental, consequential or exemplary damages, howsoever arising, even if Fisher has been advised of the possibility of such damages.